Skip to content

Continuous Epidural Contrast

Continuous Epidural Contrast - CEC

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000018847
Enrollment
9
Registered
2015-09-01
Start date
2015-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The patients required for the CT-guide procedure such as embolism of liver artery and radiofrequency of liver, which needed the epidural analgesia

Interventions

anesthetics

Sponsors

Department of Anesthesiology and Resuscitology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients with acquired consent 2) Conscious patients enable to do the conversation

Exclusion criteria

Exclusion criteria: 1) allergy for contrast 2) Renal dysfunction (Serum Creatinin 2.0 mg/dL) 3)Liver dysfunction (Serum AST/ALT >100 mg/dL) 4)Severe Heart dysfunction (Ejection fraction <40%) 5)Convulsion 6)Severe asthma 7)Thyroid dysfunction 8) Diabetes using the medicine piganaid

Design outcomes

Primary

MeasureTime frame
Our main outcome would be the possibility of continuous epidural contrast according to the diagnosis by authorized radiologists through the CT scan at the end of the procedure.

Secondary

MeasureTime frame
We will collect the information regarding the safety whether to mixture the contrast with the anesthetics (0.75% ropivacaine). In addition to that, we will collect the side effects or deleterious information regarding this research such as allergy of contrast.

Countries

Japan

Contacts

Public ContactTakashi Matsusaki

OKAYAMA UNIVERSITY HOSPITAL Intensive Care Unit

matusakik@ybb.ne.jp+819013223409

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026